ACER THERAPEUTS Cash Flow - Annual (NASDAQ:ACER)

Add to My Stocks
$30.88 $0.2 (0.65%) ACER stock closing price Sep 20, 2018 (Closing)

The financial analysis of ACER requires an investor to check the cash flows for ACER THERAPEUTS. While its important to look at the ACER THERAPEUTS debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as ACER THERAPEUTS revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. ACER THERAPEUTS had cash and cash equivalents of $1.83M at beginning of the year and $15.64M at year end for 2017. ACER THERAPEUTS cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. ACER THERAPEUTS had an outflow of $-14.09M from operating activities, $26.93M inflow due to financing activities, and $- outflow due to investing activities for 2017.

View details of ACER THERAPEUTS cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-14.19M-7.98M-12.01M-15.05M-16.65M-8.93M-5.96M-5.46M-1.43M-11.85M
Depreciation Depletion Amortization Cash-Flow----2.07M-----
Net Increase (Decrease) in Assets Liabilities-0.56M-3.23M--0.79M4.73M-0.59M--0.07M--0.9M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-1.77M-1.26M3.72M---1.01M1.95M
Net Cash from (used by) Operating Activities
-14.09M-9.2M-10.51M-14.19M-6.12M-8.92M-4.98M-4.37M-0.01M-10.56M
Increase (Decrease) in Prop Plant And Equipment-0.06M--0.09M-0.19M-0.25M-0.55M-0.29M-0.03M--0.03M
Acquisition Disposition of Subsidiaires1.03M---------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----1M-1M----
Net Cash from (used by) Investment Activities
---0.09M-0.19M--1.55M-0.29M-0.03M--0.03M
Issuance (Purchase) of Equity Shares21.5M-13.28M-28.48M-8.61M-5.82M9.25M
Issuance (Repayment) of Debt Securities5.5M----4.08M-0.03M-0.06M1.18M-
Increase (Decrease) in Bank & Other Borrowings--0.18M-------0.06M-0.05M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.06M-0.08M---0.14M-0.5M----
Net Cash from (used by) Financing Activities
26.93M-13.28M-28.43M3.95M8.58M-6.94M9.19M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
13.81M-9.13M2.67M-13.73M23.05M-6.51M3.29M-4.36M6.93M-1.4M
Cash & Equivalents at Beginning of Year1.83M12.58M9.9M23.64M-7.1M3.81M8.18M1.24M2.64M
Cash & Equivalents at Year End15.64M3.44M12.58M9.9M23.64M-7.1M3.81M8.18M1.24M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

ACER THERAPEUTS stock comparison chart provides an easy way to compare the stock price with peers along with details of ACER THERAPEUTS stock price history.
The statement of cash flows can be categorized into three main sections:

  • ACER THERAPEUTS saw a positive change in Net Change in Cash and Cash Equivalents of $13.81M in 2017. Apart from the ACER THERAPEUTS stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-14.09M for ACER.
  • Cash from investing stood at a negative value of $- for ACER stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $26.93M for ACER THERAPEUTS.

Key Financial Ratios For ACER THERAPEUTS Cash Flow

FCF margin
0